DESolve Nx Novolimus-Eluting PLLA-Based BRS: First Report of the 6-month OCT and 12-month Clinical and Imaging Results

Presenter: Stefan Verheye

REGISTER for free or LOG IN to view this content

DESolve Nx Novolimus-Eluting PLLA-Based BRS: First Report of the 6-month OCT and 12-month Clinical and Imaging Results

We Recommend